Project organization

To achieve project objectives ABIRISK is organized in 5 Working Packages (WPs).


Main relationship between ABIRISK WPs:

WPs

 

WP1: "ADA assay development and validation and cohort management"

WP1 team leaders:
Medizinische Universität Innsbruck Florian Deisenhammer
UCB Pharma S.A. Louis Christodoulou
GlaxoSmithKline Research & Development Limited Mary Birchler


WP2: "Cellular characterization and mechanisms of the AD immune response"

WP2 team leaders:
University College London Claudia Mauri
Pfizer Limited Tim Hickling
Sanofi-Aventis Research and Development Vincent Mikol


WP3: "Evaluation and development of technologies for predicting immunogenicity"

WP3 team leaders:
Commissariat a L'Energie Atomique et aux Energies Alternatives Bernard Maillère
Novartis Pharma AG Sebastian Spindeldreher
Novo Nordisk A/S Christian Ross Pedersen


WP4: "Establishment of a data base, data analyses and integration"

WP4 team leaders:
Institut National de la Santé et de la Recherche Médicale Philippe Broet
SciCross AB Pierre Dönnes
Sanofi-Aventis Research and Development Agnes Hincelin-Mery


WP5: "Project management and communication"

WP5 team leaders:
Novartis Pharma AG Sebastian Spindeldreher
Institut National de la Santé et de la Recherche Médicale Marc Pallardy
GlaxoSmithKline Research & Development Limited Steven Etheridge
Institut National de la Santé et de la Recherche Médicale Sophie Tourdot
ALTA - Ricerca e Sviluppo in Biotecnologie S.r.l.u. Riccardo Bertini